Shanghai Henlius Biotech (2696) Announces EGM and Proposes New Distribution Framework with Sinopharm Group

Bulletin Express12-03

Shanghai Henlius Biotech, Inc. (Stock Code: 2696) has issued a notice of its Extraordinary General Meeting (EGM) to be held on Wednesday, 31 December 2025, at 9:00 a.m. in Xuhui District, Shanghai. The session will consider and vote on the proposed renewal of the Distribution Framework Agreement dated 3 December 2025 between Shanghai Henlius Biotech, Inc. and Sinopharm Group Co. Ltd.*

The agenda includes approving the transactions and annual caps contemplated under the renewed agreement. Shareholders shown on the register by Wednesday, 31 December 2025 are entitled to vote, with registration closed from 24 December 2025 to 31 December 2025 inclusive. Proxies must be submitted at least 24 hours before the meeting. Holders may attend and vote in person or through an appointed proxy, bearing their own expenses for travel and accommodation.

*For identification purpose only

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1169492479?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-03 22:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1169492479","market":"hk","top_or_hot":-1,"title":"Shanghai Henlius Biotech (2696) Announces EGM and Proposes New Distribution Framework with Sinopharm Group","media":"Bulletin Express","content":"<p>Shanghai Henlius Biotech, Inc. (Stock Code: 2696) has issued a notice of its Extraordinary General Meeting (EGM) to be held on Wednesday, 31 December 2025, at 9:00 a.m. in Xuhui District, Shanghai. The session will consider and vote on the proposed renewal of the Distribution Framework Agreement dated 3 December 2025 between Shanghai Henlius Biotech, Inc. and Sinopharm Group Co. Ltd.*</p>\n<p>The agenda includes approving the transactions and annual caps contemplated under the renewed agreement. Shareholders shown on the register by Wednesday, 31 December 2025 are entitled to vote, with registration closed from 24 December 2025 to 31 December 2025 inclusive. Proxies must be submitted at least 24 hours before the meeting. Holders may attend and vote in person or through an appointed proxy, bearing their own expenses for travel and accommodation.</p>\n<p>*For identification purpose only</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Henlius Biotech (2696) Announces EGM and Proposes New Distribution Framework with Sinopharm Group</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Henlius Biotech (2696) Announces EGM and Proposes New Distribution Framework with Sinopharm Group\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-03 22:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Henlius Biotech, Inc. (Stock Code: 2696) has issued a notice of its Extraordinary General Meeting (EGM) to be held on Wednesday, 31 December 2025, at 9:00 a.m. in Xuhui District, Shanghai. The session will consider and vote on the proposed renewal of the Distribution Framework Agreement dated 3 December 2025 between Shanghai Henlius Biotech, Inc. and Sinopharm Group Co. Ltd.*</p>\n<p>The agenda includes approving the transactions and annual caps contemplated under the renewed agreement. Shareholders shown on the register by Wednesday, 31 December 2025 are entitled to vote, with registration closed from 24 December 2025 to 31 December 2025 inclusive. Proxies must be submitted at least 24 hours before the meeting. Holders may attend and vote in person or through an appointed proxy, bearing their own expenses for travel and accommodation.</p>\n<p>*For identification purpose only</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02696","symbol_name":"复宏汉霖","start_time":0,"source_url":"","article_id":"1169492479","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1169492479","pubTimestamp":1764770781,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Henlius Biotech, Inc. (Stock Code: 2696) has issued a notice of its Extraordinary General Meeting (EGM) to be held on Wednesday, 31 December 2025, at 9:00 a.m. in Xuhui District, Shanghai....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02696":"复宏汉霖"},"translate_title":"复宏汉霖生物(2696)公布临时股东大会并与国药集团提出新分销框架","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02696":1},"content_text":"Shanghai Henlius Biotech, Inc. (Stock Code: 2696) has issued a notice of its Extraordinary General Meeting (EGM) to be held on Wednesday, 31 December 2025, at 9:00 a.m. in Xuhui District, Shanghai. The session will consider and vote on the proposed renewal of the Distribution Framework Agreement dated 3 December 2025 between Shanghai Henlius Biotech, Inc. and Sinopharm Group Co. Ltd.*\nThe agenda includes approving the transactions and annual caps contemplated under the renewed agreement. Shareholders shown on the register by Wednesday, 31 December 2025 are entitled to vote, with registration closed from 24 December 2025 to 31 December 2025 inclusive. Proxies must be submitted at least 24 hours before the meeting. Holders may attend and vote in person or through an appointed proxy, bearing their own expenses for travel and accommodation.\n*For identification purpose only","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"corporation,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1169492479","isCrawlerRequest":true}